On 23 January 2018, the EMA launched a survey to gather information from marketing authorisation holders of centrally authorised medicines who are located in the UK or who have quality control, batch release and/or import manufacturing sites, or a QPPV or pharmacovigilance system master file (PSMF), in the UK, on their plans to submit transfers, notificatio...